Nanoform Finland (private company)
we tracked 3 investors
Total investments received (USD) - we tracked 2 transactions
Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. Implementing CESS offers new technological and business advantages for the pharmaceutical industry.